FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anthony Shields

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Bone Marrow

Co-author Network

Publications

TOP 3
Todd M Bauer; Bassel F El-Rayes; Nazik Hammad; Xiaobai Li; Philip A Philip; Anthony F Shields; Mark M Zalupski; Tanios Bekaii-Saab
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trials.
bruce hillner; Bruce Quinn; Anthony F Shields; Barry A Siegel; Fenghai Duan; Ilana F Gareen; Lucy Hanna; R Edward Coleman
Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts.
Steven R Alberts; Emily Chan; Gist H Farr; Sharlene Gill; Axel Grothey; Morton S Kahlenberg; Michelle R Mahoney; Margaret Mooney; Suresh Nair; Barbara A Pockaj; James T Quesenberry; Daniel J Sargent; Anthony F Shields; Frank A Sinicrope; Thomas C Smyrk; Stephen N Thibodeau; Thomas A Webb; Richard M Goldberg
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anthony Shields (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Todd M Bauer; Bassel F El-Rayes; Nazik Hammad; Xiaobai Li; Philip A Philip; Anthony F Shields; Mark M Zalupski; Tanios Bekaii-Saab
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trials.
Cancer 2013;119(2):285-92.
2012: bruce hillner; Bruce Quinn; Anthony F Shields; Barry A Siegel; Fenghai Duan; Ilana F Gareen; Lucy Hanna; R Edward Coleman
Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(5):831-7.
2012: Steven R Alberts; Emily Chan; Gist H Farr; Sharlene Gill; Axel Grothey; Morton S Kahlenberg; Michelle R Mahoney; Margaret Mooney; Suresh Nair; Barbara A Pockaj; James T Quesenberry; Daniel J Sargent; Anthony F Shields; Frank A Sinicrope; Thomas C Smyrk; Stephen N Thibodeau; Thomas A Webb; Richard M Goldberg
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.
JAMA : the journal of the American Medical Association 2012;307(13):1383-93.
2012: Richard Wiegand; Jianmei Wu; Patricia M LoRusso; Anthony F Shields; Jing Li
Simultaneous determination of 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) 5-methyluracil (FMAU) in human plasma by liquid chromatography/tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2012;891-892():64-70.
2012: Anthony F Shields
PET imaging of tumor growth: not as easy as it looks.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(5):1189-91.
2011: Patricia M LoRusso; Thomas Puchalski; Anthony F Shields; Ulka Nitin Vaishampayan; John Xu; Shirish M Gadgeel; Tina Guthrie; Qi Liu
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study.
Investigational new drugs 2011;29(6):1395-405.
2011: Basil F El-Rayes; Philip A Philip; Asfar S Azmi; Anthony F Shields; Ann Marie Ferris; Kenneth Hess; Ahmad O Kaseb; Milind M Javle; Gauri R Varadhachary; Robert A Wolff; James L Abbruzzese
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer.
Investigational new drugs 2011;29(4):694-9.
2011: Nazik Hammad; Lance K Heilbrun; Sachin Gupta; Nishant Tageja; Philip A Philip; Anthony F Shields; Daryn Smith; Basil F El-Rayes
Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experience.
American journal of clinical oncology 2011;34(2):135-9.
2011: bruce hillner; Barry A Siegel; Anthony F Shields; Fenghai Duan; Ilana F Gareen; Lucy Hanna; R Edward Coleman
Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011;13(1):161-5.
2011: Lisa R Rogers; Patricia M LoRusso; Paul Nadler; Ghaus Malik; Anthony F Shields; William Kaelin
Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report.
Journal of neuro-oncology 2011;101(2):307-10.
2010: Sachin Gupta; Venkata Parsa; Volkan Adsay; Lance K Heilbrun; Daryn Smith; Anthony F Shields; Donald Willard Weaver; Philip A Philip; Basil F El-Rayes
Clinicopathological analysis of primary epithelial appendiceal neoplasms.
Medical oncology (Northwood, London, England) 2010;27(4):1073-8.
2010: Basil F El-Rayes; Pallavi Jasti; Richard K Severson; Khaldoun Almhanna; Philip A Philip; Anthony F Shields; Mark M Zalupski; Lance K Heilbrun
Impact of race, age, and socioeconomic status on participation in pancreatic cancer clinical trials.
Pancreas 2010;39(7):967-71.
2010: Basil F El-Rayes; Mark M Zalupski; T Bekai-Saab; Lance K Heilbrun; N Hammad; Bhaumik B Patel; Susan G Urba; Anthony F Shields; Ulka Nitin Vaishampayan; S Dawson; Khaldoun Almhanna; D Smith; Philip A Philip
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(10):1999-2004.
2010: Nazik Hammad; Lance K Heilbrun; Philip A Philip; Anthony F Shields; Mark M Zalupski; Raghu Venkatramanamoorthy; Basil F El-Rayes
CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy.
Asia-Pacific journal of clinical oncology 2010;6(2):98-105.
2010: Minsig Choi; Lance K Heilbrun; Raghu Venkatramanamoorthy; Jawana M Lawhorn-Crews; Mark M Zalupski; Anthony F Shields
Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.
American journal of clinical oncology 2010;33(3):257-61.
2010: R Edward Coleman; bruce hillner; Anthony F Shields; Fenghai Duan; Denise A Merlino; Lucy G Hanna; Sharon Hartson Stine; Barry A Siegel
PET and PET/CT reports: observations from the National Oncologic PET Registry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(1):158-63.
2009: Sridhar Nimmagadda ; Thomas J Mangner; Jawana M Lawhorn-Crews; Uwe Haberkorn; Anthony F Shields
Herpes simplex virus thymidine kinase imaging in mice with (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-uracil).
European journal of nuclear medicine and molecular imaging 2009;36(12):1987-93.
2009: Amy M Weise; Chin Y Liu; Anthony F Shields
Fatal liver failure in a patient on acetaminophen treated with sunitinib malate and levothyroxine.
The Annals of pharmacotherapy 2009;43(4):761-6.
2009: bruce hillner; Barry A Siegel; Anthony F Shields; Dawei Liu; Ilana F Gareen; Lucy Hanna; Sharon Hartson Stine; R Edward Coleman
The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.
Cancer 2009;115(2):410-8.
2008: bruce hillner; Barry A Siegel; Anthony F Shields; Dawei Liu; Ilana F Gareen; Ed Hunt; R Edward Coleman
Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(12):1928-35.
2008: Sridhar Nimmagadda ; Anthony F Shields
The role of DNA synthesis imaging in cancer in the era of targeted therapeutics.
Cancer metastasis reviews 2008;27(4):575-87.
2008: Anthony F Shields
Preface-imaging in cancer.
Cancer metastasis reviews 2008;27(4):543-4.
2008: Omid S Tehrani; Kirk A Douglas; Jawana M Lawhorn-Crews; Anthony F Shields
Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2.
European journal of nuclear medicine and molecular imaging 2008;35(8):1480-8.
2008: Anthony F Shields; Jawana M Lawhorn-Crews; David A Briston; Sajad Zalzala; Shirish M Gadgeel; Kirk A Douglas; Thomas J Mangner; Lance K Heilbrun; Otto Muzik
Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4463-8.
2008: James R Bading; Anthony F Shields
Imaging of cell proliferation: status and prospects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49 Suppl 2():64S-80S.
2008: bruce hillner; Barry A Siegel; Dawei Liu; Anthony F Shields; Ilana F Gareen; Lucy Hanna; Sharon Hartson Stine; R Edward Coleman
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(13):2155-61.
2008: James W Fletcher; Benjamin Djulbegovic; Heloisa P Soares; Barry A Siegel; Val J. Lowe; Gary H Lyman; R Edward Coleman; Richard L Wahl; John Christopher Paschold; Norbert Avril; Lawrence H Einhorn; W Warren Suh; David Samson; Dominique Delbeke; Mark Gorman; Anthony F Shields
Recommendations on the use of 18F-FDG PET in oncology.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(3):480-508.
2008: Basil F El-Rayes; Mark M Zalupski; Stephanie G Manza; Barbara Rusin; Ann Marie Ferris; Ulka Nitin Vaishampayan; Lance K Heilbrun; Raghu Venkatramanamoorthy; Anthony F Shields; Philip A Philip
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.
Cancer chemotherapy and pharmacology 2008;61(2):283-9.
2007: bruce hillner; Dawei Liu; R Edward Coleman; Anthony F Shields; Ilana F Gareen; Lucy Hanna; Sharon Hartson Stine; Barry A Siegel
The National Oncologic PET Registry (NOPR): design and analysis plan.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(11):1901-8.
2007: Omid S Tehrani; Otto Muzik; Lance K Heilbrun; Kirk A Douglas; Jawana M Lawhorn-Crews; Haihao Sun; Thomas J Mangner; Anthony F Shields
Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(9):1436-41.
2007: Basil F El-Rayes; Mark M Zalupski; Anthony F Shields; Stephanie G Manza; Patricia M LoRusso; Philip A Philip
A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin.
American journal of clinical oncology 2007;30(2):101-5.
2007: Sridhar Nimmagadda ; Thomas J Mangner; Kirk A Douglas; Otto Muzik; Anthony F Shields
Biodistribution, PET, and radiation dosimetry estimates of HSV-tk gene expression imaging agent 1-(2'-Deoxy-2'-18F-Fluoro-beta-D-arabinofuranosyl)-5-iodouracil in normal dogs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):655-60.
2007: Matthew J Lindsay; Barry A Siegel; Sean R. Tunis; bruce hillner; Anthony F Shields; Brian P Carey; R Edward Coleman
The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development.
AJR. American journal of roentgenology 2007;188(4):1109-13.
2007: Ulka Nitin Vaishampayan; Lance K Heilbrun; Anthony F Shields; Jawana M Lawhorn-Crews; Karen Baranowski; Daryn Smith; Lawrence E Flaherty
Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma.
Investigational new drugs 2007;25(1):69-75.
2006: Basil F El-Rayes; Shirish M Gadgeel; Anthony F Shields; Stephanie G Manza; Patricia M LoRusso; Philip A Philip
Phase I study of bryostatin 1 and gemcitabine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7059-62.
2006: Fangyu Peng; Xin Lu; James Janisse; Otto Muzik; Anthony F Shields
PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1649-52.
2006: Anthony F Shields
Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(3):141-50.
2006: Haihao Sun; Jerry M Collins; Thomas J Mangner; Otto Muzik; Anthony F Shields
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
Cancer chemotherapy and pharmacology 2006;57(3):343-8.
2006: Iyad Jafar; Ying Hao; Anthony F Shields; Otto Muzik
Computerized detection of lung tumors in PET/CT images.
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 2006;1():2320-3.
2005: Basil F El-Rayes; Mark M Zalupski; Anthony F Shields; Ann Marie Ferris; Ulka Nitin Vaishampayan; Lance K Heilbrun; Raghu Venkatramanamoorthy; Volkan Adsay; Philip A Philip
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
Investigational new drugs 2005;23(6):583-90.
2005: Sridhar Nimmagadda ; Thomas J Mangner; Haihao Sun; Raymond W Klecker; Otto Muzik; Jawana M Lawhorn-Crews; Kirk A Douglas; Jerry M Collins; Anthony F Shields
Biodistribution and radiation dosimetry estimates of 1-(2'-deoxy-2'-(18)F-Fluoro-1-beta-D-arabinofuranosyl)-5-bromouracil: PET imaging studies in dogs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(11):1916-22.
2005: Anthony F Shields; David A Briston; Samatha Chandupatla; Kirk A Douglas; Jawana M Lawhorn-Crews; Jerry M Collins; Thomas J Mangner; Lance K Heilbrun; Otto Muzik
A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention.
European journal of nuclear medicine and molecular imaging 2005;32(11):1269-75.
2005: Cynthia G Leichman; Jacqueline K Benedetti; Mark M Zalupski; Howard Hochster; Anthony F Shields; Heinz-Josef Lenz; James L Wade Iii; James D Bearden Iii; John S Macdonald
Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study.
Clinical colorectal cancer 2005;5(2):119-23.
2005: Basil F El-Rayes; Anthony F Shields; Mark M Zalupski; Lance K Heilbrun; Vikash Jain; Damita Terry; Ann Marie Ferris; Philip A Philip
A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary.
American journal of clinical oncology 2005;28(2):152-6.
2005: Attila Megyeri; Zsolt Bacsó; Anthony F Shields; James F Eliason
Development of a stereological method to measure levels of fluoropyrimidine metabolizing enzymes in tumor sections using laser scanning cytometry.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2005;64(2):62-71.
2005: Haihao Sun; Thomas J Mangner; Jerry M Collins; Otto Muzik; Kirk Douglas; Anthony F Shields
Imaging DNA synthesis in vivo with 18F-FMAU and PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(2):292-6.
2005: David A Mankoff; Anthony F Shields; Kenneth A Krohn
PET imaging of cellular proliferation.
Radiologic clinics of North America 2005;43(1):153-67.
2005: Haihao Sun; Andrew E Sloan; Thomas J Mangner; Ulka Nitin Vaishampayan; Otto Muzik; Jerry M Collins; Kirk Douglas; Anthony F Shields
Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer.
European journal of nuclear medicine and molecular imaging 2005;32(1):15-22.
2005: Basil F El-Rayes; Dina Ibrahim; Anthony F Shields; Patricia M LoRusso; Mark M Zalupski; Philip A Philip
Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors.
Investigational new drugs 2005;23(1):57-62.
2004: Basil F El-Rayes; Anthony F Shields; Mark M Zalupski; Lance K Heilbrun; Vikash Jain; D Terry; Ann Marie Ferris; Philip A Philip
A phase II study of carboplatin and paclitaxel in esophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(6):960-5.
2004: Edgar Ben-Josef; Anthony F Shields; Ulka Nitin Vaishampayan; Vainutis K Vaitkevicius; Basil F El-Rayes; Patrick McDermott; Jay Burmeister; Todd Bossenberger; Philip A Philip
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
International journal of radiation oncology, biology, physics 2004;59(2):454-9.
2004: Anthony F Shields; Mark M Zalupski; John L Marshall; Neal J Meropol
Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trial.
Cancer 2004;100(3):531-7.
2004: Ying Hao; Fule Zhou; Anthony F Shields; Otto Muzik; Dafang Wu; Elisabeth Iljas Heath
A novel computerized approach to enhancing lung tumor detection in whole-body PET images.
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 2004;3():1589-92.
2004: Chin Y Liu; Vikash Jain; Anthony F Shields; Lance K Heilbrun
Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer.
Journal of vascular and interventional radiology : JVIR 2004;15(1 Pt 1):39-44.
2003: Sana Al-Sukhun; Mark M Zalupski; Edgar Ben-Josef; Vainutis K Vaitkevicius; Philip A Philip; Renate Soulen; Donald Willard Weaver; Volkan Adsay; Lance K Heilbrun; Kenneth Levin; Jeffrey D Forman; Anthony F Shields
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
American journal of clinical oncology 2003;26(6):543-9.
2003: Anthony F Shields
PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(9):1432-4.
2003: Basil F El-Rayes; Mark M Zalupski; Anthony F Shields; Ulka Nitin Vaishampayan; Lance K Heilbrun; V Jain; Volkan Adsay; J Day; Philip A Philip
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2920-5.
2003: Oday Hamid; Mary Varterasian; Scott Wadler; J Randolph Hecht; Al Benson; Evanthia Galanis; Margaret Uprichard; Charles Omer; Paul Bycott; Robert C Hackman; Anthony F Shields
Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1498-504.
2003: Thomas J Mangner; Raymond W Klecker; Lawrence Anderson; Anthony F Shields
Synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU.
Nuclear medicine and biology 2003;30(3):215-24.
2003: Subhash Chander; Eser Lay Ergun; Anthony F Shields
An FDG positron emission tomographic study in a case of gastrointestinal stromal tumor.
Clinical nuclear medicine 2003;28(4):327-9.
2003: Shirish M Gadgeel; Anthony F Shields; Lance K Heilbrun; Samir Labadidi; Mark M Zalupski; Ruth Chaplen; Philip A Philip
Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer.
American journal of clinical oncology 2003;26(1):37-41.
2003: Basil F El-Rayes; Anthony F Shields; Vainutis K Vaitkevicius; Philip A Philip
Developments in the systemic therapy of pancreatic cancer.
Cancer investigation 2003;21(1):73-86.
2003: Nat L Pernick; Asfar S Azmi; Philip A Philip; Patricia Arlauskas; Anthony F Shields; Vainutis K Vaitkevicius; Michael C Dugan; N Volkan Adsay
Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians.
Pancreas 2003;26(1):28-32.
2003: Haihao Sun; Jerry M Collins; Thomas J Mangner; Otto Muzik; Anthony F Shields
Imaging [18F]FAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil] in dogs.
Nuclear medicine and biology 2003;30(1):25-30.
2002: Subhash Chander; Eser Lay Ergun; Harry T Chugani; Diane C Chugani; Csaba Juhász; Anthony F Shields; Donald Willard Weaver
High 2-deoxy-2-[18F]fluoro-D-glucose accumulation in a case of retroperitoneal fibrosis following resection of carcinoid tumor.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2002;4(5):363-8.
2002: Ulka Nitin Vaishampayan; Edgar Ben-Josef; Philip A Philip; Vainutis K Vaitkevicius; Wei Du; Kenneth Levin; Anthony F Shields
A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies.
International journal of radiation oncology, biology, physics 2002;53(3):675-9.
2002: Patricia M LoRusso; Sucharu Prakash; Antoinette J Wozniak; Lawrence E Flaherty; Mark M Zalupski; Anthony F Shields; Howard Sands; Ralph E Parchment; Bhaskara R Jasti
Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU).
Investigational new drugs 2002;20(1):63-71.
2002: Anthony F Shields; John R Grierson; Otto Muzik; Joseph C Stayanoff; Jawana M Lawhorn-Crews; Joyce E Obradovich; Thomas J Mangner
Kinetics of 3'-deoxy-3'-[F-18]fluorothymidine uptake and retention in dogs.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2002;4(1):83-9.
2001: Kambiz Merati; M said Siadaty; Aleodor Andea; Asfar S Azmi; Edgar Ben-Josef; Ramzi M Mohammad; Philip A Philip; Anthony F Shields; Vainutis K Vaitkevicius; David Grignon; N Volkan Adsay
Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters.
American journal of clinical oncology 2001;24(5):447-52.
2001: Philip A Philip; Mark M Zalupski; Vainutis K Vaitkevicius; Patricia Arlauskas; Ruth Chaplen; Lance K Heilbrun; Volkan Adsay; Donald Willard Weaver; Anthony F Shields
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.
Cancer 2001;92(3):569-77.
2001: Anthony F Shields; L M Lange; Mark M Zalupski
Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer.
American journal of clinical oncology 2001;24(1):96-8.
2001: Jeffrey A Zonder; Anthony F Shields; Mark M Zalupski; Ruth Chaplen; Lance K Heilbrun; Patricia Arlauskas; Philip A Philip
A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(1):38-42.
2000: Wei Du; Daniel Touchette; Vainutis K Vaitkevicius; W P Peters; Anthony F Shields
Cost analysis of pancreatic carcinoma treatment.
Cancer 2000;89(9):1917-24.
2000: S Ahmed; Vainutis K Vaitkevicius; Mark M Zalupski; Wei Du; Patricia Arlauskas; C Gordon; C Kellogg; Anthony F Shields
Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
American journal of clinical oncology 2000;23(4):420-4.
2000: John R Grierson; Anthony F Shields
Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo.
Nuclear medicine and biology 2000;27(2):143-56.
2000: D A Mankoff; F Dehdashti; Anthony F Shields
Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.
Neoplasia (New York, N.Y.) 2000;2(1-2):71-88.
1999: Anthony F Shields; P T Ho; John R Grierson
The role of imaging in the development of oncologic agents.
Journal of clinical pharmacology 1999;Suppl():40S-44S.
1999: Philip A Philip; Dina Ibrahim; Mark M Zalupski; Patricia Arlauskas; Anthony F Shields
Gemcitabine and UFT plus oral calcium folinate: phase I study.
Oncology (Williston Park, N.Y.) 1999;13(7 Suppl 3):116-9.
1999: David A Mankoff; Anthony F Shields; Jeanne M Link; Michael M Graham; Mark Muzi; Lanell M Peterson; Janet F Eary; Kenneth A Krohn
Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(4):614-24.
1999: Anthony F Shields; Philip A Philip; Patricia M LoRusso; Ann Marie Ferris; Mark M Zalupski
Phase II study of CI-958 in colorectal cancer.
Cancer chemotherapy and pharmacology 1999;43(2):162-4.
1998: Anthony F Shields; John R Grierson; Bernhard M Dohmen; Hans-Jürgen Machulla; J C Stayanoff; Jawana M Lawhorn-Crews; Joyce E Obradovich; Otto Muzik; Thomas J Mangner
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.
Nature medicine 1998;4(11):1334-6.
1998: Anthony F Shields; David A Mankoff; Jeanne M Link; Michael M Graham; Janet F Eary; S M Kozawa; M Zheng; Barbara Lewellen; Thomas K Lewellen; John R Grierson; Kenneth A Krohn
Carbon-11-thymidine and FDG to measure therapy response.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(10):1757-62.
1998: C Germann; Anthony F Shields; John R Grierson; I Morr; Uwe Haberkorn
5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(8):1418-23.
1998: David A Mankoff; Anthony F Shields; Michael M Graham; Jeanne M Link; Janet F Eary; Kenneth A Krohn
Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(6):1043-55.
1998: Mark M Zalupski; Anthony F Shields; Philip A Philip; M Kraut; Patricia M LoRusso; Lance K Heilbrun; Vainutis K Vaitkevicius
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.
Investigational new drugs 1998;16(1):93-6.
1998: Ramzi M Mohammad; Michael C Dugan; Anwar N Mohamed; VP Almatchy; T M Flake; ST Dergham; Anthony F Shields; Ayad Al-Katib; Vainutis K Vaitkevicius; Asfar S Azmi
Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.
Pancreas 1998;16(1):19-25.
1997: Philip A Philip; Mark M Zalupski; Shirish M Gadgeel; Maha Hussain; Anthony F Shields
A phase II study of carboplatin and paclitaxel in the treatment of patients with advanced esophageal and gastric cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-86-S19-88.
1997: Mark M Zalupski; Philip A Philip; Patricia M LoRusso; Anthony F Shields
Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma.
Cancer chemotherapy and pharmacology 1997;40(3):225-7.
1996: David A Mankoff; Anthony F Shields; Michael M Graham; Jeanne M Link; Kenneth A Krohn
A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(12):2049-57.
1996: Anthony F Shields; David A Mankoff; Michael M Graham; M Zheng; S M Kozawa; Jeanne M Link; Kenneth A Krohn
Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(2):290-6.
1996: Anthony F Shields; John R Grierson; S M Kozawa; M Zheng
Development of labeled thymidine analogs for imaging tumor proliferation.
Nuclear medicine and biology 1996;23(1):17-22.
1995: John R Grierson; Anthony F Shields; M Zheng; S M Kozawa; J H Courter
Radiosyntheses of labeled beta-pseudothymidine ([C-11]- and [H-3]methyl) and its biodistribution and metabolism in normal and tumored mice.
Nuclear medicine and biology 1995;22(5):671-8.
1994: B R Hoane; Anthony F Shields; B A Porter; J W Borrow
Comparison of initial lymphoma staging using computed tomography (CT) and magnetic resonance (MR) imaging.
American journal of hematology 1994;47(2):100-5.
1993: JA Thompson; CG Lindgren; M C Benyunes; J A Bianco; Anthony F Shields; Alexander Fefer
The effects of pentoxifylline on the generation of human lymphokine-activated killer cell cytotoxicity.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;13(2):84-90.
1992: Anthony F Shields; Michael M Graham; S M Kozawa; Laura B Kozell; Jeanne M Link; E R Swenson; Alexander M Spence; James B Bassingthwaighte; Kenneth A Krohn
Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(4):581-4.
1991: J A Bianco; Frederick R Appelbaum; John Nemunaitis; J Almgren; F Andrews; P Kettner; Anthony F Shields; J W Singer
Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation.
Blood 1991;78(5):1205-11.
1991: B R Hoane; Anthony F Shields; B A Porter; H M Shulman
Detection of lymphomatous bone marrow involvement with magnetic resonance imaging.
Blood 1991;78(3):728-38.
1990: Anthony F Shields; K Lim; John R Grierson; J Link; Kenneth A Krohn
Utilization of labeled thymidine in DNA synthesis: studies for PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(3):337-42.
1989: Anthony F Shields; F R Applebaum; T Graham; H Joachim Deeg; J Allalunis-Turner; J D Chapman; Rainer Storb
Bone marrow toxicity of total-body irradiation combined with radiosensitizers.
Radiation research 1989;120(2):364-9.
1988: R C Quackenbush; Anthony F Shields
Local re-utilization of thymidine in normal mouse tissues as measured with iododeoxyuridine.
Cell and tissue kinetics 1988;21(6):381-7.
1988: E D Agura; E Vila; F B Petersen; Anthony F Shields; ED Thomas
The use of ranitidine in bone marrow transplantation. A review of 223 cases.
Transplantation 1988;46(1):53-6.
1988: Anthony F Shields; J A Berenson
Procainamide-associated pancytopenia.
American journal of hematology 1988;27(4):299-301.
1987: Anthony F Shields; D V Coonrod; R C Quackenbush; J J Crowley
Cellular sources of thymidine nucleotides: studies for PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(9):1435-40.
1987: JA Thompson; Anthony F Shields; B A Porter; D O Olson; E Rubin; P Kidd; Alexander Fefer
Magnetic resonance imaging of bone marrow in hairy cell leukemia: correlation with clinical response to alpha-interferon.
Leukemia 1987;1(4):315-6.
1987: Anthony F Shields; B A Porter; S Churchley; D O Olson; F R Appelbaum; ED Thomas
The detection of bone marrow involvement by lymphoma using magnetic resonance imaging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(2):225-30.
1987: D H Webb; Anthony F Shields; Kenneth H Fife
Genomic variation of adenovirus type 5 isolates recovered from bone marrow transplant recipients.
Journal of clinical microbiology 1987;25(2):305-8.
1986: D O Olson; Anthony F Shields; C J Scheurich; B A Porter; A A Moss
Magnetic resonance imaging of the bone marrow in patients with leukemia, aplastic anemia, and lymphoma.
Investigative radiology 1986;21(7):540-6.
1986: B A Porter; Anthony F Shields; D O Olson
Magnetic resonance imaging of bone marrow disorders.
Radiologic clinics of North America 1986;24(2):269-89.
1985: Kenneth H Fife; Rhoda Ashley; Anthony F Shields; D Salter; J D Meyers; Lawrence Corey
Comparison of neutralization and DNA restriction enzyme methods for typing clinical isolates of human adenovirus.
Journal of clinical microbiology 1985;22(1):95-100.
1985: Anthony F Shields; R C Hackman; Kenneth H Fife; Lawrence Corey; J D Meyers
Adenovirus infections in patients undergoing bone-marrow transplantation.
The New England journal of medicine 1985;312(9):529-33.
1984: Anthony F Shields; Steven M Larson; Z Grunbaum; Michael M Graham
Short-term thymidine uptake in normal and neoplastic tissues: studies for PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1984;25(7):759-64.
1980: David Baltimore; Anthony F Shields; G Otto; S Goff; Peter Besmer; O Witte; N Rosenberg
Structure and expression of the Abelson murine leukemia virus genome and its relationship to a normal cell gene.
Cold Spring Harbor symposia on quantitative biology 1980;44 Pt 2,():849-54.
1979: Anthony F Shields; S Goff; M Paskind; G Otto; David Baltimore
Structure of the Abelson murine leukemia virus genome.
Cell 1979;18(4):955-62.
1979: Anthony F Shields; N Rosenberg; David Baltimore
Virus production by Abelson murine leukemia virus-transformed lymphoid cells.
Journal of virology 1979;31(2):557-67.
1979: Eli Gilboa; S Goff; Anthony F Shields; Fayth K Yoshimura; S Mitra; David Baltimore
In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus.
Cell 1979;16(4):863-74.
1978: Anthony F Shields; W N Witte; E Rothenberg; David Baltimore
High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections.
Cell 1978;14(3):601-9.
1978: O N Witte; N Rosenberg; M Paskind; Anthony F Shields; David Baltimore
Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(5):2488-92.
1976: Anthony F Shields; David Baltimore; R S Ryback
Viability of cells in ethanol. Role of alcohol dehydrogenase.
Journal of studies on alcohol 1976;37(3):321-6.